EMA Gets Application for J&J (JNJ) Vaccine for Marketing Authorization - Bloomberg
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
EMA Gets Application for J&J (NYSE: JNJ) Vaccine for Marketing Authorization - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU snubs extra 300M J&J (JNJ), Astra (AZN) shots in bet on Pfizer (PFE) - Reuters
- ENA Confirms Total Benefit-Risk of J&J (JNJ) Vaccine Remains Positive - Bloomberg
- Hoth Therapeutics Inc. (HOTH) Begins First in Human Clinical Trial for the Treatment of Atopic Dermatitis with BioLexa